Mitomycin C, Mitomycin C CAS 50-07-7, Mitomycin C for cancer, Mitomycin C mechanism, Mitomycin C ophthalmology, Mitomycin C side effects, Mitomycin C dosing, Mitomycin C chemotherapy, Mitomycin C DNA crosslinking, Mitomycin C lung cancer, Mitomycin C bladder cancer, Mitomycin C applications, Mitomycin C price, Mitomycin C suppliers, Mitomycin C safety, Mitomycin C FDA approval, Mitomycin C contraindications, Mitomycin C usage, Mitomycin C injection,
In medicine, especially oncology, mitomycin C (CAS: 50-07-7) is a powerful antibiotic and chemotherapeutic drug that is often employed. It is known for its ability to block DNA synthesis, which makes it an important medicine in cancer therapy and ocular surgery. This article provides a detailed chemical analysis, mechanism of action, health benefits, safety considerations, and prescribing information about Mitomycin C.
Benefits of Mitomycin C for Health
Treatment for Cancer: It is used to treat cancers of the stomach, bladder, breast, and lungs.
Ophthalmic Use: Applied in glaucoma surgery to reduce scarring.
In order to increase effectiveness, adjuvants are often employed in conjunction with other chemotherapeutic drugs.
Possible Impacts
DNA Crosslinking: Forms crosslinks between DNA strands, limiting cell division and promoting death.
Tumor Suppression: A useful treatment for malignant cells that divide quickly.
Anti-fibrotic Properties: Prevents excessive scarring after surgery.
Action Mechanism
Mitomycin C is a bioreductive alkylating agent. When activated by enzymes, it produces reactive oxygen species (ROS) and creates crosslinks in DNA, particularly at guanine bases. This inhibits DNA replication, causing the cell cycle to arrest in rapidly proliferating cells, particularly tumors.
Safety Factors
Storage: Should be stored at 2-8°C and protected from light.
Handling Precautions: Requires careful handling with protective equipment due to its cytotoxic nature.
The administration of this medication should be carried out under the supervision of a qualified medical professional.
Adverse Reactions
Hematological Toxicity: Myelosuppression, anemia, leukopenia, and thrombocytopenia.
Interstitial pneumonia and pulmonary fibrosis are two possible outcomes of pulmonary toxicity.
Nephrotoxicity: Long-term usage may cause kidney damage.
GI effects include feeling sick, throwing up, and having diarrhea.
Rash, skin pigmentation, and inflammation at the injection site are examples of these types of dermatological reactions.
Information on Dosage
IV use: 10-20 mg/m2 every 6-8 weeks.
Treatment for Bladder Cancer: 20–40 mg given intravenously in 40 mL of sterile water.
Ophthalmic Use: When performing glaucoma surgery, diluted version is used topically.
Contraindications
Pregnancy and lactation: Not advised owing to teratogenic risk.
Patients with substantial hematological deficiencies are contraindicated from receiving this medication due to severe bone marrow suppression.
Dysfunction of the Renal System: Patients whose kidneys aren't working properly should be used with care.
Lung Disease: Those who already have pulmonary disorders should not use this product.
In conclusion
The versatile antibiotic and chemotherapeutic mitomycin C has several uses, although it is most often used in the fields of cancer and ophthalmology. It is a successful alternative against a variety of malignancies due to its method of action, which involves DNA crosslinking. However, myelosuppression, lung toxicity, and nephrotoxicity are serious side effects. To guarantee safe and efficient administration, proper medical monitoring is necessary.
People Inquire
1. How does Mitomycin C work to cure cancer?
Mitomycin C serves as a DNA crosslinking agent that impedes the replication of cancer cells. By making covalent links between DNA strands, it stops cells from dividing, which kills tumor cells that are multiplying too quickly.
2. Is it safe to use mitomycin C for therapies other than cancer?
Mitomycin C is used in a variety of medical procedures, including ocular operations and therapies for bladder cancer, despite its primary application in breast cancer treatment. As a cytotoxic substance, it must be handled cautiously and administered under medical supervision.
3. What are Mitomycin C's most typical adverse effects?
The most common adverse effects include bone marrow suppression, lung toxicity, renal damage, and gastrointestinal abnormalities. Risks must be reduced by routine monitoring.
4. Can combination therapy be implemented with Mitomycin C?
Mitomycin C is often mixed with other chemotherapy drugs, like fluorouracil or cisplatin, to make treatment work better. This is especially true for people with lung and stomach cancers.
5. When dealing with mitomycin C, what safety measures should be ensured?
Similar Competitive Products
Bleomycin (CAS: 11056-06-7) – Another DNA-damaging chemotherapeutic antibiotic.
Doxorubicin (CAS: 23214-92-8) – A widely used anthracycline antibiotic for various cancers.
Cisplatin (CAS: 15663-27-1) – A platinum-based chemotherapy drug.
Gemcitabine (CAS: 95058-81-4) – An antimetabolite chemotherapy agent.
Fluorouracil (CAS: 51-21-8) – A pyrimidine analog used in chemotherapy.
When handling Mitomycin C, doctors must use gloves and masks. To avoid contamination, it should be kept in a dark, cool place and disposed of appropriately after use.
6. How long does Mitomycin C take to start working?
The disease being treated determines the impact of mitomycin C. Results from chemotherapy may be seen within weeks, but the benefits of ophthalmology on wound healing can be seen within days.
